Dr Gwenda Simons’ current research looks at perspectives of individuals in different pre-Rheumatoid arthritis phases on issues such as risk perception, predictive testing and preventative medicine. Her research further looks at patient preferences in benefit risk assessments during the drug life cycle within the IMI PREFER consortium. She is also involved in research looking at the perceptions of rheumatoid arthritis (RA) and decisions to seek help for RA symptoms in the general public as well as research looking at the perceptions of pharmacists and pharmacy assistants of RA and the sign posting of patients with joint problems.